Cryptobiotix, a preclinical research organization specializing in microbiome modeling, has launched its biobank, a dedicated storage solution for cryo-stabilized gut microbiome samples that are sourced, characterized, and stored under proprietary conditions that preserve both structure and function. Co-founded by Aurélien Baudot and Dr. Pieter van den Abbeele, Cryptobiotix was established to address the “Valley of Death” in preclinical testing — the slow and often inaccurate traditional methods that can jeopardize product development.
